About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 937061, 9 pages
http://dx.doi.org/10.1155/2011/937061
Research Article

Intravesical Dimethyl Sulfoxide Inhibits Acute and Chronic Bladder Inflammation in Transgenic Experimental Autoimmune Cystitis Models

1Department of Urology, Northwestern University, Chicago, IL 60611-3008, USA
2Department of Urology, University of Iowa, Iowa City, IA 52242-1089, USA

Received 8 September 2010; Accepted 20 October 2010

Academic Editor: Oreste Gualillo

Copyright © 2011 Ronald Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Warren, J. Brown, J. K. Tracy, P. Langenberg, U. Wesselmann, and P. Greenberg, “Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women,” Urology, vol. 71, no. 3, pp. 444–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. O. Selo-Ojeme and J. L. Onwude, “Interstitial cystitis,” Journal of Obstetrics and Gynaecology, vol. 24, no. 3, pp. 216–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Sairanen, M. Leppilahti, T. L. J. Tammela et al., “Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it,” Scandinavian Journal of Urology and Nephrology, vol. 43, no. 3, pp. 212–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. N. E. Rothrock, S. K. Lutgendorf, A. Hoffman, and K. J. Kreder, “Depressive symptoms and quality of life in patients with interstitial cystitis,” Journal of Urology, vol. 167, no. 4, pp. 1763–1767, 2002. View at Scopus
  5. T. L. Ratliff, C. G. Klutke, M. Hofmeister, F. He, J. H. Russell, and M. J. Becich, “Role of the immune response in interstitial cystitis,” Clinical Immunology and Immunopathology, vol. 74, no. 3, pp. 209–216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. van de Merwe, “Interstitial cystitis and systemic autoimmune diseases,” Nature Clinical Practice Urology, vol. 4, no. 9, pp. 484–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Peeker, L. Atanasiu, and Y. Logadottir, “Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis,” Scandinavian Journal of Urology and Nephrology, vol. 37, no. 1, pp. 60–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Westropp and C. A. T. Buffington, “In vivo models of interstitial cystitis,” Journal of Urology, vol. 167, no. 2, pp. 694–702, 2002. View at Scopus
  9. A. D. Bullock, M. J. Becich, C. G. Klutke, and T. L. Ratliff, “Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis,” Journal of Urology, vol. 148, no. 6, pp. 1951–1956, 1992. View at Scopus
  10. Y.-H. Lin, G. Liu, M. Kavran et al., “Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis,” British Journal of Urology International, vol. 102, no. 11, pp. 1724–1730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Phull, M. Salkini, T. Purves, J. Funk, D. Copeland, and C. V. Comiter, “Angiotensin II plays a role in acute murine experimental autoimmune cystitis,” British Journal of Urology International, vol. 100, no. 3, pp. 664–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mitra, A. Dagher, R. Kage, R. K. Dagher, and J. Luber-Narod, “Experimental autoimmune cystitis: further characterization and serum autoantibodies,” Urological Research, vol. 27, no. 5, pp. 351–356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Luber-Narod, T. Austin-Ritchie, B. Banner et al., “Experimental autoimmune cystitis in the Lewis rat: a potential animal model for interstitial cystitis,” Urological Research, vol. 24, no. 6, pp. 367–373, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Liu, D. P. Evanoff, X. Chen, and Y. Luo, “Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response,” Journal of Immunology, vol. 178, no. 1, pp. 539–546, 2007. View at Scopus
  15. C. Kurts, W. R. Heath, F. R. Carbone et al., “Constitutive class I-restricted exogenous presentation of self antigens in vivo,” Journal of Experimental Medicine, vol. 184, no. 3, pp. 923–930, 1996. View at Scopus
  16. W. Liu and Y. Luo, “Interruption of mast cell function effectively inhibits bladder inflammation in an autoimmune cystitis model,” Journal of Urology, vol. 179, pp. 62–63, 2008.
  17. W. Liu, B. R. DeYoung, X. Chen, D. P. Evanoff, and Y. Luo, “RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model,” Journal of Autoimmunity, vol. 30, no. 4, pp. 257–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. C. Santos, J. Figueira-Coelho, J. Martins-Silva, and C. Saldanha, “Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects,” Biochemical Pharmacology, vol. 65, no. 7, pp. 1035–1041, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. R. Sant, “Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis,” Urology, vol. 29, no. 4, supplement, pp. 17–21, 1987. View at Scopus
  20. J. Parkin, C. Shea, and G. R. Sant, “Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis—a practical approach,” Urology, vol. 49, no. 5, pp. 105–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Perez-Marrero, L. E. Emerson, and J. T. Feltis, “A controlled study of dimethyl sulfoxide in interstitial cystitis,” Journal of Urology, vol. 140, no. 1, pp. 36–39, 1988. View at Scopus
  22. J. Rössberger, M. Fall, and R. Peeker, “Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome,” Scandinavian Journal of Urology and Nephrology, vol. 39, no. 1, pp. 73–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Peeker, M.-A. Haghsheno, S. Holmäng, and M. Fall, “Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study,” Journal of Urology, vol. 164, no. 6, pp. 1912–1916, 2000. View at Scopus
  24. G. M. Ghoniem, D. McBride, O. P. Sood, and V. Lewis, “Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy,” World Journal of Urology, vol. 11, no. 3, pp. 178–182, 1993. View at Scopus
  25. L. Stout, J. M. Gerspach, S. M. Levy et al., “Dimethyl sulfoxide does not trigger urine histamine release in interstitial cystitis,” Urology, vol. 46, no. 5, pp. 653–656, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Tyagi, V. C. Hsieh, N. Yoshimura, J. Kaufman, and M. B. Chancellor, “Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity,” British Journal of Urology International, vol. 104, no. 11, pp. 1689–1692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Soler, H. Bruschini, J. C. Truzzi et al., “Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis,” International Brazilian Journal of Urology, vol. 34, no. 4, pp. 503–511, 2008.
  28. Y. Sun and T. C. Chai, “Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis,” British Journal of Urology International, vol. 90, no. 4, pp. 381–385, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-I. Shiga, K. Hirano, J. Nishimura, N. Niiro, S. Naito, and H. Kanaide, “Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus,” British Journal of Pharmacology, vol. 151, no. 7, pp. 1014–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Melchior, C. S. Packer, T. C. Johnson, and M. Kaefer, “Dimethyl sulfoxide: does it change the functional properties of the bladder wall?” Journal of Urology, vol. 170, no. 1, pp. 253–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. Birder, A. J. Kanai, and W. C. De Groat, “DMSO: effect on bladder afferent neurons and nitric oxide release,” Journal of Urology, vol. 158, no. 5, pp. 1989–1995, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-T. Liu, P. Tyagi, M. B. Chancellor, and H.-C. Kuo, “Urinary nerve growth factor level is increased in patients with interstitial cystitis-bladder pain syndrome and decreased in responders to treatment,” British Journal of Urology International, vol. 104, no. 10, pp. 1476–1481, 2009. View at Publisher · View at Google Scholar
  33. M. Lotz, P. Villiger, T. Hugli, J. Koziol, and B. L. Zuraw, “Interleukin-6 and interstitial cystitis,” Journal of Urology, vol. 152, no. 3, pp. 869–873, 1994. View at Scopus
  34. O. Trubiani, M. Ciancarelli, M. Rapino, and R. Di Primio, “Dimethyl sulfoxide induces programmed cell death and reversible G1 arrest in the cell cycle of human lymphoid pre-T cell line,” Immunology Letters, vol. 50, no. 1-2, pp. 51–57, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Liu, H. Yoshikawa, Y. Nakajima, and K. Tasaka, “Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells,” International Immunopharmacology, vol. 1, no. 1, pp. 63–74, 2001. View at Publisher · View at Google Scholar · View at Scopus